Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin J Shattock

Showing results (121-130 of 210) with videos related to

Pageof 21
Sort By:
Biomacromolecules|July 10, 2020
The <i>In Vitro</i>, <i>Ex Vivo</i>, and <i>In Vivo</i> Effect of Polymer Hydrophobicity on Charge-Reversible Vectors for Self-Amplifying RNAPratik Gurnani, Anna K Blakney, Roberto Terracciano, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 14, 2024
The role of helper lipids in optimising nanoparticle formulations of self-amplifying RNABeatriz D Barbieri, David J Peeler, Karnyart Samnuan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 7, 2007
Mycobacterium tuberculosis antigens specifically modulate CCR2 and MCP-1/CCL2 on lymphoid cells from human pulmonary hilar lymph nodesMauricio A Arias, Gabriela Jaramillo, Yúrika P López, et al.
Vaccine|April 9, 2022
A self-amplifying RNA vaccine protects against SARS-CoV-2 (D614G) and Alpha variant of concern (B.1.1.7) in a transmission-challenge hamster modelRebecca Frise, Laury Baillon, Jie Zhou, et al.
Journal of Virology|July 10, 2009
Human immunodeficiency virus type 1 nucleocapsid inhibitors impede trans infection in cellular and explant models and protect nonhuman primates from infectionGregory S Wallace, Cecilia Cheng-Mayer, Marco L Schito, et al.
Journal of Virology|April 11, 2014
Enhanced immunogenicity of an HIV-1 DNA vaccine delivered with electroporation via combined intramuscular and intradermal routesJamie F S Mann, Paul F McKay, Anezka Fiserova, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 1, 2026
BODIPY Photocage-Based Injectable Hydrogel for Light-Controlled Nanoparticle ReleaseBaihao Shao, David J Peeler, Thomas F F Fernandez Debets, et al.
Journal of Materials Chemistry. B|May 29, 2020
Ornithine-derived oligomers and dendrimers for in vitro delivery of DNA and ex vivo transfection of skin cells via saRNAFrancesca Saviano, Tatiana Lovato, Annapina Russo, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2011
Antiviral breadth and combination potential of peptide triazole HIV-1 entry inhibitorsKaryn McFadden, Patricia Fletcher, Fiorella Rossi, et al.
Plos One|July 26, 2012
Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140Mauricio A Arias, Griet A Van Roey, John S Tregoning, et al.
Pageof 21

Showing results (121-130 of 210) with videos related to

Sort By:
Pageof 21
Biomacromolecules|July 10, 2020
The <i>In Vitro</i>, <i>Ex Vivo</i>, and <i>In Vivo</i> Effect of Polymer Hydrophobicity on Charge-Reversible Vectors for Self-Amplifying RNAPratik Gurnani, Anna K Blakney, Roberto Terracciano, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 14, 2024
The role of helper lipids in optimising nanoparticle formulations of self-amplifying RNABeatriz D Barbieri, David J Peeler, Karnyart Samnuan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 7, 2007
Mycobacterium tuberculosis antigens specifically modulate CCR2 and MCP-1/CCL2 on lymphoid cells from human pulmonary hilar lymph nodesMauricio A Arias, Gabriela Jaramillo, Yúrika P López, et al.
Vaccine|April 9, 2022
A self-amplifying RNA vaccine protects against SARS-CoV-2 (D614G) and Alpha variant of concern (B.1.1.7) in a transmission-challenge hamster modelRebecca Frise, Laury Baillon, Jie Zhou, et al.
Journal of Virology|July 10, 2009
Human immunodeficiency virus type 1 nucleocapsid inhibitors impede trans infection in cellular and explant models and protect nonhuman primates from infectionGregory S Wallace, Cecilia Cheng-Mayer, Marco L Schito, et al.
Journal of Virology|April 11, 2014
Enhanced immunogenicity of an HIV-1 DNA vaccine delivered with electroporation via combined intramuscular and intradermal routesJamie F S Mann, Paul F McKay, Anezka Fiserova, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 1, 2026
BODIPY Photocage-Based Injectable Hydrogel for Light-Controlled Nanoparticle ReleaseBaihao Shao, David J Peeler, Thomas F F Fernandez Debets, et al.
Journal of Materials Chemistry. B|May 29, 2020
Ornithine-derived oligomers and dendrimers for in vitro delivery of DNA and ex vivo transfection of skin cells via saRNAFrancesca Saviano, Tatiana Lovato, Annapina Russo, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2011
Antiviral breadth and combination potential of peptide triazole HIV-1 entry inhibitorsKaryn McFadden, Patricia Fletcher, Fiorella Rossi, et al.
Plos One|July 26, 2012
Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140Mauricio A Arias, Griet A Van Roey, John S Tregoning, et al.
Pageof 21